Sung Lee is EVP, Chief Financial Officer of CYTOKINETICS INC. Currently has a direct ownership of 34,684 shares of CYTK, which is worth approximately $1.77 Million. The most recent transaction as insider was on May 31, 2024, when has been sold 34,684 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.7K
0% 3M change
n/a 12M change
Total Value Held $1.77 Million

Sung Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2024
BUY
Grant, award, or other acquisition
-
34,684 Added 50.0%
34,684 Common Stock

Also insider at

SGMO
SANGAMO THERAPEUTICS, INC Healthcare
VIR
Vir Biotechnology, Inc. Healthcare
SL

Sung Lee

EVP, Chief Financial Officer
Brisbane, CA

Track Institutional and Insider Activities on CYTK

Follow CYTOKINETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYTK shares.

Notify only if

Insider Trading

Get notified when an Cytokinetics Inc insider buys or sells CYTK shares.

Notify only if

News

Receive news related to CYTOKINETICS INC

Track Activities on CYTK